Polytherapy including apremilast and TYK2 inhibitors

MA55781AUndetermined Publication Date: 2022-03-09CELGENE CORP
0 Cites 0 Cited by

Patent Information

Application Number
MA55781
Authority / Receiving Office
MA · MA
Patent Type
Applications
Current Assignee / Owner
Filing Date
2019-04-30
Publication Date
2022-03-09
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.